WO2002051810A3 - Ligands des recepteurs des integrines - Google Patents

Ligands des recepteurs des integrines Download PDF

Info

Publication number
WO2002051810A3
WO2002051810A3 PCT/EP2001/014924 EP0114924W WO02051810A3 WO 2002051810 A3 WO2002051810 A3 WO 2002051810A3 EP 0114924 W EP0114924 W EP 0114924W WO 02051810 A3 WO02051810 A3 WO 02051810A3
Authority
WO
WIPO (PCT)
Prior art keywords
integrin receptor
receptor ligands
ligands
integrin
compounds
Prior art date
Application number
PCT/EP2001/014924
Other languages
German (de)
English (en)
Other versions
WO2002051810A2 (fr
Inventor
Herve Geneste
Andreas Kling
Udo Lange
Arnulf Lauterbach
Werner Seitz
Claudia Isabella Graef
Thomas Subkowski
Wilfried Hornberger
Michael Kluge
Rainer Spriesterbach
Original Assignee
Abbott Gmbh & Co Kg
Herve Geneste
Andreas Kling
Udo Lange
Arnulf Lauterbach
Werner Seitz
Claudia Isabella Graef
Thomas Subkowski
Wilfried Hornberger
Michael Kluge
Rainer Spriesterbach
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg, Herve Geneste, Andreas Kling, Udo Lange, Arnulf Lauterbach, Werner Seitz, Claudia Isabella Graef, Thomas Subkowski, Wilfried Hornberger, Michael Kluge, Rainer Spriesterbach filed Critical Abbott Gmbh & Co Kg
Publication of WO2002051810A2 publication Critical patent/WO2002051810A2/fr
Publication of WO2002051810A3 publication Critical patent/WO2002051810A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des composés qui se lient aux récepteurs des intégrines, leur utilisation en tant que ligands des récepteurs des intégrines, en particulier en tant que ligands du récepteur de l'intégrine αvβ3, leur utilisation, ainsi que des préparations pharmaceutiques contenant ces composés.
PCT/EP2001/014924 2000-12-22 2001-12-18 Ligands des recepteurs des integrines WO2002051810A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10064823.1 2000-12-22
DE10064823A DE10064823A1 (de) 2000-12-22 2000-12-22 Integrinrezeptorliganden

Publications (2)

Publication Number Publication Date
WO2002051810A2 WO2002051810A2 (fr) 2002-07-04
WO2002051810A3 true WO2002051810A3 (fr) 2003-03-20

Family

ID=7668842

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/014924 WO2002051810A2 (fr) 2000-12-22 2001-12-18 Ligands des recepteurs des integrines

Country Status (2)

Country Link
DE (1) DE10064823A1 (fr)
WO (1) WO2002051810A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101204247B1 (ko) 2003-07-22 2012-11-22 아스텍스 테라퓨틱스 리미티드 3,4-이치환된 1h-피라졸 화합물 및 그의 시클린 의존성키나제 (cdk) 및 글리코겐 합성효소 키나제-3(gsk-3) 조정제로서 용도
AR047894A1 (es) 2004-02-25 2006-03-01 Wyeth Corp Derivados de tiofeno como inhibidores de la proteina tirosina fosfatasa 1b (ptpasa 1b); metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por ptpasa 1b
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
US8329703B2 (en) 2005-02-15 2012-12-11 Xtl Biopharmaceuticals Ltd. Pyrazole compounds
JP2010506843A (ja) 2006-10-13 2010-03-04 エックスティーエル バイオファーマシューティカルズ リミテッド Hcvを治療するための化合物および方法
KR20200030584A (ko) 2017-07-21 2020-03-20 앤타바이오 에스에이에스 화합물
JP7429799B2 (ja) 2020-02-18 2024-02-08 ギリアード サイエンシーズ, インコーポレイテッド 抗ウイルス化合物
TWI775313B (zh) 2020-02-18 2022-08-21 美商基利科學股份有限公司 抗病毒化合物
TW202322824A (zh) 2020-02-18 2023-06-16 美商基利科學股份有限公司 抗病毒化合物
EP4323362A1 (fr) 2021-04-16 2024-02-21 Gilead Sciences, Inc. Procédés de préparation de carbanucléosides à l'aide d'amides
US12116380B2 (en) 2021-08-18 2024-10-15 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036862A1 (fr) * 1996-03-29 1997-10-09 G.D. Searle & Co. DERIVES DE PHENYLENE META-SUBSTITUES, UTILISES COMME ANTAGONISTES OU INHIBITEURS DE L'INTEGRINE ALPHAvBETA¿3?
WO2000009503A1 (fr) * 1998-08-13 2000-02-24 Merck & Co., Inc. Antagonistes de recepteurs d'integrine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036862A1 (fr) * 1996-03-29 1997-10-09 G.D. Searle & Co. DERIVES DE PHENYLENE META-SUBSTITUES, UTILISES COMME ANTAGONISTES OU INHIBITEURS DE L'INTEGRINE ALPHAvBETA¿3?
WO2000009503A1 (fr) * 1998-08-13 2000-02-24 Merck & Co., Inc. Antagonistes de recepteurs d'integrine

Also Published As

Publication number Publication date
DE10064823A1 (de) 2002-06-27
WO2002051810A2 (fr) 2002-07-04

Similar Documents

Publication Publication Date Title
HUP0200803A3 (en) Substituted bicyclic heteroaryl compounds as integrin antagonists, pharmaceutical compositions containing them and the intermediates
WO2003084943A3 (fr) Derives de terphenyle, leur preparation, les compositions pharmaceutiques en contenant
BR0209242A (pt) Aminopolidiorganossiloxanos amido-funcionais
AP2003002916A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
WO2001032646A3 (fr) Nouveaux composes
HK1055955A1 (en) Methanesulphonamido-benzofuran, preparation methodand use thereof as synthesis intermediate.
IL150225A0 (en) Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof
HUP0203108A3 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
AU2001241056A1 (en) Spiro compounds, process for preparing the same and use thereof as drugs
WO2002051810A3 (fr) Ligands des recepteurs des integrines
MY135916A (en) Use of certain affinity nmda antagonists as antidepressants
IL149427A0 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
HUP0201571A3 (en) Il-8 receptor antagonist phenyl urea derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HK1052007A1 (en) Novel heterocyclic derivatives, preparation methodand pharmaceutical compositions containing same.
ZA200201521B (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparation containing the same, and methods of using the same.
WO2003039456A3 (fr) Procede de preparation de ligands de recepteurs de la thyroide derives d'aniline
DK1958938T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
HK1045684A1 (en) Biphenyl derivatives as antagonists of the neurokinine-1 receptor.
WO2000061551A3 (fr) Ligands de recepteurs d'integrine
WO2003097597A3 (fr) Derives d'indole et leur utilisation en tant que ligands des recepteurs cb2
HUP0300928A3 (en) Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
MXPA02012015A (es) Ligandos de receptores para integrinas.
HUP0303804A3 (en) Ligands of the avss6 integrin, process for their preparation, their use and pharmaceutical compositions containing them
AU4543200A (en) Pharmaceutical or cosmetic compositions for the local, intradermal application of hormones

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP